Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Berkshire Hathaway under Greg Abel signals a sharper eye for AI champions. Could Alphabet be the catalyst, with Nvidi...
Netflix is set to release its Q2 earnings after the bell tonight, with investors watching ad revenue growth, content ...
XRP nears a fifth straight red monthly candle, a pattern last seen in 2016-2017. Traders weigh whether history could ...
AI is reshaping how businesses operate. This guide argues why a select software stock fits a once-in-a-decade opportu...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
A JPMorgan analyst forecasts looming oil shortages within weeks, drawing a sharp response from investors and fund man...
Deutsche Bank upgrades Humana to Buy with a near-doubling price target, as analysts anticipate a 2026 rebound in Medi...
U.S. health insurers rise as analysts forecast margin recovery and cost discipline. Humana jumps, UnitedHealth climbs...
Bitcoin fans have watched a calm stretch emerge around the $60,000 mark. This article breaks down what that steady vi...
IREN is staking its growth on a 1.4 GW Australian AI infrastructure push valued at about $22 billion, anchored by the...
Antero Resources is attracting takeover chatter as major energy players weigh bids. With strong cash flow and LNG exp...